NAMM 2026: Laurel is out, rosewood is in for all but entry-level models, as upgrades come across the board ...

Johnson & Johnson has brought its bladder cancer drug TAR-200 to the US market, a year after its prospects were dented by a negative phase 3 readout. The novel formulation of the stalwart ...

With the Sebring on the way out, convertible buyers will enjoy the new 200 for its brand-new stylish look, low price and solid feature list. Base prices are expected to start under $20,000, and such ...